Diana Driscoll, O.D. continues to produce compelling research and updated formulas for the treatment of dry eye. The U.S. Patent Office has now awarded Dr. Driscoll and Genetic Disease Investigators, LLC a second patent, authenticating the formula’s value as a unique treatment option.
Dr. Driscoll’s formula works through the body’s autonomic nervous system, stimulating the release and production of specific neurotransmitters that aid in tear production.
For an expanded summary on this dry eye patent, see the press release, “New Patent Awarded for Dry Eye Treatment”, published on PRNewswire.
Or see the full text of U.S. Patent No. 10,238,673 B2, “Methods and compositions for treatment of dry eye and correction of organ dysfunctions”